| Alembic Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 533573 |
NSE Symbol : APLLTD |
P/E(TTM) : 27.06 |
|
ISIN Demat : INE901L01018 |
Div & Yield% : 1.04 |
EPS(TTM) : 38.99 |
|
Book Value(₹) : 255.98 |
Market Cap(₹Cr) : 20,737.41 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 5,874.06 | 5,149.00 | 5,035.41 | 5,066.89 | 4,132.55 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 5,874.06 | 5,149.00 | 5,035.41 | 5,066.89 | 4,132.55 |
| Other Income | 31.32 | 3.54 | 51.14 | 83.90 | 134.75 |
| Stock Adjustments | 52.36 | -72.84 | -19.85 | 160.65 | 176.50 |
| Total Income | 5,957.74 | 5,079.70 | 5,066.70 | 5,311.44 | 4,443.80 |
| EXPENDITURE : | |||||
| Raw Materials | 1,852.71 | 1,587.29 | 1,482.36 | 1,464.67 | 1,222.39 |
| Power and Fuel Cost | 173.32 | 151.19 | 120.50 | 118.31 | 97.43 |
| Other Manufacturing Expenses | 327.87 | 357.21 | 324.10 | 344.44 | 291.44 |
| Selling and Administration Expenses | 1,191.90 | 1,173.00 | 1,088.67 | 848.55 | 661.00 |
| Miscellaneous Expenses | 46.19 | 48.31 | 28.82 | 26.07 | 37.52 |
| Employee Benefit Expenses | 1,335.91 | 1,094.82 | 1,062.30 | 976.13 | 806.37 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,029.84 | 667.88 | 959.95 | 1,533.27 | 1,327.65 |
| Interest | 54.47 | 49.00 | 17.02 | 12.98 | 25.19 |
| Gross Profit | 975.37 | 618.88 | 942.93 | 1,520.29 | 1,302.46 |
| Depreciation | 271.14 | 272.95 | 284.92 | 182.55 | 135.67 |
| Profit Before Tax | 704.23 | 345.93 | 658.01 | 1,337.74 | 1,166.79 |
| Current Tax | 37.75 | -0.80 | 114.46 | 241.20 | 197.39 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | - | - | - | - | - |
| Reported Net Profit | 666.48 | 346.73 | 543.55 | 1,096.54 | 969.40 |
| Extraordinary Items | 0.99 | 0.05 | 2.81 | 5.20 | -7.06 |
| Adjusted Net Profit | 665.49 | 346.68 | 540.74 | 1,091.34 | 976.46 |
| Adjustment below Net Profit | - | - | -76.31 | -114.90 | -51.00 |
| Profit/Loss Balance carried down | 3,651.68 | 2,632.89 | 2,440.83 | 1,709.19 | 1,296.49 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 157.25 | -672.07 | 275.19 | 250.00 | 525.97 |
| P & L Balance carried down | 4,160.91 | 3,651.69 | 2,632.88 | 2,440.83 | 1,688.92 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 550.00 | 400.00 | 500.00 | 700.00 | 500.00 |
| Dividend Per Share(Rs) | 11.00 | 8.00 | 10.00 | 14.00 | 10.00 |
| Earnings Per Share-Unit Curr | 33.91 | 17.64 | 27.65 | 55.79 | 51.43 |
| Earnings Per Share(Adj)-Unit Curr | 33.91 | 17.64 | 27.65 | 55.79 | 51.43 |
| Book Value | 249.75 | 224.59 | 269.16 | 259.57 | 177.51 |
| Book Value(Adj)-Unit Curr | 249.75 | 224.59 | 269.16 | 259.57 | 177.51 |